ArticleAge and ageing2026
Mapping the landscape of geriatric medicine education, training and practice in Europe.
Article in Age and ageing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Mapping Geriatric Medicine education in Portuguese medical schools.European geriatric medicine · 2026Article
- The development of the European Geriatric Medicine Specialty Exam.European geriatric medicine · 2026Article
- Unmet educational needs in geriatric care among interdisciplinary professionals working in ambulatory and home care settings: a pan-European survey by the PROGRAMMING COST Action 21122.Age and ageing · 2026Article
- Why do residents choose to specialize in geriatric medicine?European geriatric medicine · 2026Article
- Time for Gen Z doctors to care for older patients.European geriatric medicine · 2026Article
- Prevalence and range of geriatric medicine services across Europe: a survey of 39 countries.European geriatric medicine · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
14 authors.
Funding
Abstract
introductionGeriatric Medicine (GM) has evolved in Europe over the past few decades, although variably across countries. The aim of this paper is to explore the GM specialty status, postgraduate and undergraduate education for medical students, nurses and Allied Health Professionals (AHPs), academic development and GM clinical services in Europe.
methodsWe collected cross-sectional data from 38 European countries as listed by the World Health Organization with an online quantitative survey. This study is part of the PROGRAMMING COST Action, which stands for PROmoting GeRiAtric Medicine in countries where it is still eMergING and is funded by the European Cooperation for Science and Technology.
resultsGM is recognised as a distinct specialty in 24 countries (63.15%), while specialty training is available in 21 countries (55.26%). Principles of GM are included in the undergraduate curricula for medical students in all or most medical universities in 24 countries (63.15%), for nurses in 26 countries (68.42%) and for AHPs in 19 countries (50%). Geriatric hospital wards are present in 28 countries (73.68%), and in eight countries, there are no GM clinical services available, especially in Southern Europe. GM is a standalone academic discipline in 20 countries (52.63%), and advanced academic doctoral study is available in 18 countries (47.36%). GM is more established in Northern and Western Europe.
conclusionOur study highlights the inconsistent development of GM across European countries. It provides a foundation for policy development and educational reform to meet the needs of Europe's ageing population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.